201 related articles for article (PubMed ID: 33724574)
1. Follicle-stimulating hormone promotes growth of human prostate cancer cell line-derived tumor xenografts.
Oduwole OO; Poliandri A; Okolo A; Rawson P; Doroszko M; Chrusciel M; Rahman NA; Serrano de Almeida G; Bevan CL; Koechling W; Huhtaniemi IT
FASEB J; 2021 Apr; 35(4):e21464. PubMed ID: 33724574
[TBL] [Abstract][Full Text] [Related]
2. FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist.
Crawford ED; Tombal B; Keane T; Boccardo F; Miller K; Shore N; Moul JW; Damber JE; Collette L; Persson BE
Scand J Urol; 2018; 52(5-6):349-357. PubMed ID: 30624128
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone and its agonist inhibit testicular luteinizing hormone receptor and steroidogenesis in immature and adult hypophysectomized rats.
Bambino TH; Schreiber JR; Hsueh AJ
Endocrinology; 1980 Oct; 107(4):908-17. PubMed ID: 6250797
[TBL] [Abstract][Full Text] [Related]
4. Developments in the control of testicular function.
Swerdloff RS; Wang C; Bhasin S
Baillieres Clin Endocrinol Metab; 1992 Apr; 6(2):451-83. PubMed ID: 1377467
[TBL] [Abstract][Full Text] [Related]
5. Regulation of testicular steroidogenesis by gonadotropin-releasing hormone agonists and antagonists.
Huhtaniemi I; Nikula H; Rannikko S; Clayton R
J Steroid Biochem; 1986 Jan; 24(1):169-76. PubMed ID: 3009972
[TBL] [Abstract][Full Text] [Related]
6. GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 Expression.
Cucchiara V; Yang JC; Liu C; Adomat HH; Tomlinson Guns ES; Gleave ME; Gao AC; Evans CP
Mol Cancer Ther; 2019 Oct; 18(10):1811-1821. PubMed ID: 31341032
[TBL] [Abstract][Full Text] [Related]
7. Testosterone selectively increases serum follicle-stimulating hormonal (FSH) but not luteinizing hormone (LH) in gonadotropin-releasing hormone antagonist-treated male rats: evidence for differential regulation of LH and FSH secretion.
Bhasin S; Fielder TJ; Swerdloff RS
Biol Reprod; 1987 Aug; 37(1):55-9. PubMed ID: 3115326
[TBL] [Abstract][Full Text] [Related]
8. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin subunit messenger RNA concentrations after blockade of gonadotropin-releasing hormone action: testosterone selectively increases follicle-stimulating hormone beta-subunit messenger RNA by posttranscriptional mechanisms.
Paul SJ; Ortolano GA; Haisenleder DJ; Stewart JM; Shupnik MA; Marshall JC
Mol Endocrinol; 1990 Dec; 4(12):1943-55. PubMed ID: 1707128
[TBL] [Abstract][Full Text] [Related]
10. Testosterone and dihydrotestosterone, but not estradiol, selectively maintain pituitary and serum follicle-stimulating hormone in gonadotropin-releasing hormone antagonist treated male rats.
Arslan M; Weinbauer GF; Khan SA; Nieschlag E
Neuroendocrinology; 1989 Apr; 49(4):395-401. PubMed ID: 2497399
[TBL] [Abstract][Full Text] [Related]
11. Suppression of pituitary-testis function in rats treated neonatally with a gonadotrophin-releasing hormone agonist and antagonist: acute and long-term effects.
Kolho KL; Huhtaniemi I
J Endocrinol; 1989 Oct; 123(1):83-91. PubMed ID: 2509621
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate.
Santen RJ; Warner B
Urology; 1985 Feb; 25(2 Suppl):53-7. PubMed ID: 3918377
[TBL] [Abstract][Full Text] [Related]
13. Degarelix: a gonadotropin-releasing hormone antagonist for the management of prostate cancer.
Steinberg M
Clin Ther; 2009; 31 Pt 2():2312-31. PubMed ID: 20110043
[TBL] [Abstract][Full Text] [Related]
14. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
15. Effects of testosterone on gonadotropin subunit messenger ribonucleic acids in the presence or absence of gonadotropin-releasing hormone.
Winters SJ; Ishizaka K; Kitahara S; Troen P; Attardi B
Endocrinology; 1992 Feb; 130(2):726-34. PubMed ID: 1370794
[TBL] [Abstract][Full Text] [Related]
16. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
17. Pituitary-gonadal axis before puberty: evaluation of testicular steroids in the male rat.
Eldrige JC; Mahesh VB
Biol Reprod; 1974 Nov; 11(4):385-97. PubMed ID: 4457143
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin gene expression and secretion in gonadotropin-releasing hormone antagonist-treated male rats: effect of sex steroid replacement.
Perheentupa A; Huhtaniemi I
Endocrinology; 1990 Jun; 126(6):3204-9. PubMed ID: 1693570
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone, estradiol, and inhibin regulation of follicle-stimulating hormone and luteinizing hormone surges: implications for follicle emergence and selection in heifers.
Haughian JM; Ginther OJ; Diaz FJ; Wiltbank MC
Biol Reprod; 2013 Jun; 88(6):165. PubMed ID: 23658431
[TBL] [Abstract][Full Text] [Related]
20. A comparative study on the efficacies of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist in neoadjuvant androgen deprivation therapy combined with transperineal prostate brachytherapy for localized prostate cancer.
Miki K; Sasaki H; Kido M; Takahashi H; Aoki M; Egawa S
BMC Cancer; 2016 Sep; 16(1):708. PubMed ID: 27586506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]